<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03823404</url>
  </required_header>
  <id_info>
    <org_study_id>COR388-010</org_study_id>
    <nct_id>NCT03823404</nct_id>
  </id_info>
  <brief_title>GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease</brief_title>
  <official_title>GAIN Trial: A Randomized, Double-Blind, Placebo-Controlled Study of COR388 in Subjects With Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cortexyme Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cortexyme Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blind, placebo-controlled study that will assess the efficacy,
      safety, and tolerability of 2 dose levels of COR388 in subjects with a clinical diagnosis of
      mild to moderate AD dementia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, double-blind, placebo-controlled study that will assess the efficacy,
      safety, and tolerability of 2 dose levels of COR388 oral capsules in subjects with probable
      AD dementia according to the National Institute on Aging-Alzheimer's Association (NIA-AA)
      criteria. The study will enroll approximately 573 generally healthy male and female subjects
      ≥55 and ≤80 years of age. Enrolled subjects must have a documented diagnosis of mild to
      moderate AD dementia. The subject should not have other conditions or brain imaging
      abnormalities that can explain the symptoms of dementia. All subjects will be encouraged to
      have LPs (during screening, week 24 and week 48) in the absence of medical conditions that
      can increase the risk of the procedure in the opinion of the Investigator. Cerebrospinal
      fluid (CSF), saliva, and blood will be analyzed for measurements of biomarkers of AD and
      neuroinflammation, and for the presence of bacterial deoxyribonucleic acid (DNA) of
      Porphyromonas gingivalis (P. gingivalis [Pg]). A subset of sites will monitor subjects for
      clinical evidence of periodontitis at baseline, 24 and 48 weeks.

      The study will consist of 3 periods: a screening period of up to 6 weeks, a treatment period
      of up to 48 weeks, and a safety follow-up period of 6 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 28, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alzheimer's Disease Assessment Scale-Cognitive Subscale 11 (ADAS-Cog 11)</measure>
    <time_frame>Baseline to Week 48</time_frame>
    <description>Mean change in Alzheimer's Disease Assessment Scale-Cognitive Subscale 11 (ADAS-Cog 11) from baseline to the end of treatment period. ADAS-Cog 11 measures cognitive functions and non-cognitive functions such as mood and behavior. Total scores range from 0-70, with higher scores (≥ 18) indicating greater cognitive impairment. ADAS-Cog 11 score increases by 2-4 points per year on average in subjects with mild to moderate Alzheimer's Disease. A treatment period of 48 weeks was selected to allow sufficient time to demonstrate at least 2.5 points difference between active treatment and placebo on ADAS-Cog 11 at the end of the treatment period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CDR-SB</measure>
    <time_frame>Baseline to Week 48</time_frame>
    <description>Change in Clinical Dementia Rating-Sum of Boxes (CDR-SB).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ADCS-ADL</measure>
    <time_frame>Baseline to Week 48</time_frame>
    <description>Change in Alzheimer's Disease Cooperative Study Group-Activities of Daily Living (ADCS-ADL).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Mini-Mental State Examination (MMSE)</measure>
    <time_frame>Baseline to Week 48</time_frame>
    <description>Change in MMSE.</description>
  </other_outcome>
  <other_outcome>
    <measure>Neuropsychiatric Inventory (NPI)</measure>
    <time_frame>Baseline to Week 48</time_frame>
    <description>Change in NPI.</description>
  </other_outcome>
  <other_outcome>
    <measure>Cerebrospinal fluid (CSF) Porphyromonas gingivalis DNA fragments</measure>
    <time_frame>Baseline to Week 48</time_frame>
    <description>Change in CSF Porphyromonas gingivalis DNA fragments.</description>
  </other_outcome>
  <other_outcome>
    <measure>Winterlight Speech Assessment</measure>
    <time_frame>Baseline to Week 48</time_frame>
    <description>Change in Winterlight Speech Assessment.</description>
  </other_outcome>
  <other_outcome>
    <measure>Magnetic resonance imaging</measure>
    <time_frame>Baseline to Week 48</time_frame>
    <description>Change in magnetic resonance imaging.</description>
  </other_outcome>
  <other_outcome>
    <measure>Periodontal (or gum) pocket depth</measure>
    <time_frame>Baseline to Week 48</time_frame>
    <description>Change in periodontal (or gum) pocket depth.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">573</enrollment>
  <condition>Alzheimer Disease</condition>
  <arm_group>
    <arm_group_label>COR388 80 mg bid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>COR388 40 mg bid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo bid</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>COR388 capsule</intervention_name>
    <description>bid</description>
    <arm_group_label>COR388 40 mg bid</arm_group_label>
    <arm_group_label>COR388 80 mg bid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo capsule</intervention_name>
    <description>bid</description>
    <arm_group_label>Placebo bid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  Subject has probable AD dementia according to the NIA-AA criteria.

          -  Subject has an MMSE score 12 and 24 inclusive at both screening and Visit 2 and a
             ≤3-point difference between these visits.

          -  Subject has brain MRI scan consistent with the diagnosis of AD performed during the
             screening period. Computed Tomography scan can be used only if the subject has an
             absolute contraindication for MRI.

          -  Subject has a Modified Hachinski score ≤4 at screening.

          -  Subjects with background symptomatic therapy with acetylcholine esterase inhibitors,
             and/or memantine, are allowed as long as the dose has been stable for 90 days prior to
             screening and no changes are planned during the study.

          -  Subject has a primary caregiver willing to accept responsibility for supervising the
             treatment (e.g., administering study drug) and assessing the condition of the subject
             throughout the study in accordance with all protocol requirements.

          -  Subject has body mass index &lt;38 kg/m2 at Screening

        Key Exclusion Criteria:

          -  Subject has imaging consistent with a dementia diagnosis other than AD.

          -  Subject has had an increase or restoration of cognition based on medical history.

          -  Subject with history or current evidence of major psychiatric illness such as
             schizophrenia, bipolar disorder, or major depressive disorder that may interfere with
             the patient's ability to perform the study and all assessments. NOTE: Mild depression
             or depressive mood arising in the context of AD are not criteria for exclusion. The
             use of anti-depressants or the use of anti epileptic medication for non
             seizure-related treatment is allowed if the dose has remained stable for at least 60
             days prior to enrollment.

          -  Subject has any of the following laboratory findings at screening:

               1. Alanine aminotransferase &gt;3 x upper limit of normal (ULN), aspartate
                  aminotransferase &gt;3 x ULN, or history of clinically significant liver disease in
                  the Investigator's judgment.

               2. Hemoglobin ≤10 g/dl.

               3. Creatinine clearance (CL) of &lt;45 ml/min.

               4. Poorly controlled diabetes as defined by hemoglobin A1C (HbA1C) &gt;8.

               5. Positive blood screen for Human Immunodeficiency Virus (HIV 1 and 2), Hepatitis B
                  surface antigen (HBsAg), or Hepatitis C virus antibodies (HCV-Ab) at Screening.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Male and female.</gender_description>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael J Detke, MD, PhD</last_name>
    <phone>415-910-5717</phone>
    <email>clinicaltrials@cortexyme.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xenoscience, Inc.</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Randi Carr</last_name>
      <phone>602-274-9500</phone>
      <email>Rcarr@xenoscience.com</email>
    </contact>
    <investigator>
      <last_name>Stephen Flitman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Banner Alzheimer's Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenna Leger</last_name>
      <phone>602-839-4894</phone>
      <email>jenna.leger@bannerhealth.com</email>
    </contact>
    <investigator>
      <last_name>Po-Heng Tsai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Banner Sun Health</name>
      <address>
        <city>Sun City</city>
        <state>Arizona</state>
        <zip>85351</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadira Trncic</last_name>
      <phone>623-832-6590</phone>
      <email>Nadira.trncic@bannerhealth.com</email>
    </contact>
    <investigator>
      <last_name>Bryan Spann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ATP Clinical Research, Inc.</name>
      <address>
        <city>Costa Mesa</city>
        <state>California</state>
        <zip>92626</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bobby Shih</last_name>
      <phone>714-277-4472</phone>
      <email>bshih@atpcr.com</email>
    </contact>
    <investigator>
      <last_name>Gustavo Alva, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alliance Research</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90807</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Standford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Ng</last_name>
      <phone>650-485-9560</phone>
      <email>amandang@standford.edu</email>
    </contact>
    <investigator>
      <last_name>Sharron Sha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CITRIALS</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>CITRIALS</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Ann</last_name>
      <phone>714-979-4101</phone>
      <email>john.ann@citrials.com</email>
    </contact>
    <investigator>
      <last_name>Evagelos Coskinas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Syrentis Clinical Research</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Southern California Research LLC</name>
      <address>
        <city>Simi Valley</city>
        <state>California</state>
        <zip>93065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>JEM Research Institute</name>
      <address>
        <city>Atlantis</city>
        <state>Florida</state>
        <zip>33462</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meslissa Daggerhart, MBA, CCRP</last_name>
      <phone>561-968-2933</phone>
      <email>mdaggerhart@jemri.net</email>
    </contact>
    <investigator>
      <last_name>Mark Goldstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brain Matters Research</name>
      <address>
        <city>Delray Beach</city>
        <state>Florida</state>
        <zip>33445</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jetliza Lesmes</last_name>
      <phone>561-381-9060</phone>
      <email>JLESMES@ERGCLINICAL.COM</email>
    </contact>
    <investigator>
      <last_name>Mark Brody, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neuropsychiatric Research Center of Southwest Florida</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernardo Avila</last_name>
      <phone>239-939-7777</phone>
      <email>neurocontact@ergclinical.com</email>
    </contact>
    <investigator>
      <last_name>Wendy Bond, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MD Clinical</name>
      <address>
        <city>Hallandale Beach</city>
        <state>Florida</state>
        <zip>33009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evelyn Quiles</last_name>
      <phone>954-455-5757</phone>
      <phone_ext>111</phone_ext>
      <email>equiles@mdclinical.org</email>
    </contact>
    <investigator>
      <last_name>Beth Safirstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indago Research and Health Center, Inc.</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Violeta Gomez</last_name>
      <phone>305-825-6588</phone>
      <phone_ext>311</phone_ext>
      <email>vgomez@indagoresearch.org</email>
    </contact>
    <investigator>
      <last_name>Evelio Sosa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alzheimer's Research and Treatment Center</name>
      <address>
        <city>Lake Worth</city>
        <state>Florida</state>
        <zip>33449</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Lipofsky</last_name>
      <phone>561-209-2400</phone>
      <email>jlipofsky@researchalz.com</email>
    </contact>
    <investigator>
      <last_name>David Watson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Qtrials, Inc.</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Future Care Solutions, LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33165</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Miami Dade Medical Research Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramon Avellana</last_name>
      <phone>305-722-7210</phone>
      <email>ravellana@miamimedresearch.com</email>
    </contact>
    <contact_backup>
      <last_name>Mabel Cruz</last_name>
      <email>mcruz@miamimedresearch.com</email>
    </contact_backup>
    <investigator>
      <last_name>Orlando Puente, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sensible Healthcare LLC</name>
      <address>
        <city>Ocoee</city>
        <state>Florida</state>
        <zip>34761</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Taylor, MD</last_name>
      <phone>407-654-2724</phone>
      <email>drtaylor@sensiblehealthcare.net</email>
    </contact>
    <investigator>
      <last_name>Kelly Taylor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bioclinica Research</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Bubalo</last_name>
      <phone>407-841-0502</phone>
      <email>Matthew.Bubalo@bioclinica.com</email>
    </contact>
    <investigator>
      <last_name>Ira Goodman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Anchor Neuroscience</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynn Head-Jolliff, RN, BSN</last_name>
      <phone>850-433-6760</phone>
      <phone_ext>104</phone_ext>
      <email>lheadjolliff@anchorneuroscience.com</email>
    </contact>
    <investigator>
      <last_name>Kevin Groom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Suncoast Neuroscience Associates, Inc.</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chelsea Morris Rizer</last_name>
      <phone>727-202-2629</phone>
      <email>cmorris@suncoastneuroresearch.com</email>
    </contact>
    <investigator>
      <last_name>Alberto Vasquez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brain Matters Research at the Kane Center</name>
      <address>
        <city>Stuart</city>
        <state>Florida</state>
        <zip>34997</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jetliza Lesmes</last_name>
      <phone>772-223-7880</phone>
      <email>info@brainmattersresearch.com</email>
    </contact>
    <investigator>
      <last_name>Mark Brody, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stedman Clinical Trials</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maytte Dusseau</last_name>
      <phone>813-971-8311</phone>
      <email>Maytte_dusseau@StedmanClinicalTrials.com</email>
    </contact>
    <investigator>
      <last_name>Mary Stedman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columus Memory Center</name>
      <address>
        <city>Columbus</city>
        <state>Georgia</state>
        <zip>31909</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Liss, MD</last_name>
      <phone>706-653-8455</phone>
      <email>CMC@LissMD.com</email>
    </contact>
    <investigator>
      <last_name>Jonathan Liss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NeuroStudies.net, LLC</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenn Cavin</last_name>
      <phone>404-475-0552</phone>
      <email>jcavin@neurostudies.net</email>
    </contact>
    <investigator>
      <last_name>Marshall Nash, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwest Clinical Trials</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clarie Harris</last_name>
      <phone>208-225-5300</phone>
      <email>charris@nwct.com</email>
    </contact>
    <contact_backup>
      <last_name>Amanda Wells</last_name>
      <phone>208-225-5300</phone>
      <email>awells@nwct.com</email>
    </contact_backup>
    <investigator>
      <last_name>Brock McConnehey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alexian Brothers Neurosciences Research</name>
      <address>
        <city>Elk Grove Village</city>
        <state>Illinois</state>
        <zip>60007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Coates, MPH</last_name>
      <phone>847-593-8553</phone>
      <email>Jennifer.Coates@amitahealth.org</email>
    </contact>
    <investigator>
      <last_name>Concetta Forchetti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ascension Via Christi Research</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janie Krull</last_name>
      <phone>316-291-4673</phone>
      <email>Janie.krull@ascension.org</email>
    </contact>
    <contact_backup>
      <last_name>Lisa Aragon</last_name>
      <phone>316-291-4673</phone>
      <email>lisa.aragon@ascension.org</email>
    </contact_backup>
    <investigator>
      <last_name>Paul Murphy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Activmed Practices and Research</name>
      <address>
        <city>Methuen</city>
        <state>Massachusetts</state>
        <zip>01844</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Boston Center for Memory</name>
      <address>
        <city>Newton</city>
        <state>Massachusetts</state>
        <zip>02459</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Crystal Tarrago, CRC</last_name>
      <phone>617-699-6927</phone>
      <email>crystal@bostonmemory.com</email>
    </contact>
    <investigator>
      <last_name>Paul Solomon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Anil Nair MD, Alzheimer's Disease Center</name>
      <address>
        <city>Quincy</city>
        <state>Massachusetts</state>
        <zip>02169</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Memory Center</name>
      <address>
        <city>Hattiesburg</city>
        <state>Mississippi</state>
        <zip>39401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kayleigh Russell</last_name>
      <phone>601-579-5016</phone>
      <email>Kayleigh.russell@hattiesburgclinic.com</email>
    </contact>
    <investigator>
      <last_name>Richard Schwartz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Lou Ruvo Center for Brain Health</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yolande Mucharbach</last_name>
      <phone>702-685-7070</phone>
      <email>muchary@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Aaron Ritter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princeton Medical Institute</name>
      <address>
        <city>Princeton</city>
        <state>New Jersey</state>
        <zip>08540</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Pasquale</last_name>
      <phone>609-921-6050</phone>
      <email>cpasquale@gminstitutes.com</email>
    </contact>
    <investigator>
      <last_name>Olga Tchikindas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Cognitive Research Center of New Jersey</name>
      <address>
        <city>Springfield</city>
        <state>New Jersey</state>
        <zip>07081</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kavita Doshi</last_name>
      <phone>973-850-4622</phone>
      <email>kdoshi@thecrcnj.com</email>
    </contact>
    <contact_backup>
      <last_name>Chelsea Nigro</last_name>
      <phone>973-850-4622</phone>
      <email>cnigro@thecrcnj.com</email>
    </contact_backup>
    <investigator>
      <last_name>Michelle Papka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurology Specialists of Monmouth County</name>
      <address>
        <city>West Long Branch</city>
        <state>New Jersey</state>
        <zip>07764</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Albuquerque Neuroscience</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Kushner, MD</last_name>
      <phone>505-848-3773</phone>
      <email>robert@albneuro.com</email>
    </contact>
    <contact_backup>
      <last_name>Geraldine Dempsey, BSN, CCRC</last_name>
      <phone>505-848-3773</phone>
      <email>gerrie@albneuro.com</email>
    </contact_backup>
    <investigator>
      <last_name>Glen Michael Dempsey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Disease Research &amp; Neurology Center of Neurological Associates of Albany</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Holub, MD</last_name>
      <phone>518-426-0575</phone>
      <email>Research@naaresearch.com</email>
    </contact>
    <investigator>
      <last_name>Richard Holub, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Integrative Clinical Trials LLC</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Spri Clinicaltrials, Llc</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mid Hudson Medical Research</name>
      <address>
        <city>New Windsor</city>
        <state>New York</state>
        <zip>12553</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sashi Makam, MD</last_name>
      <phone>844-337-8839</phone>
      <email>crc@mhmresearch.com</email>
    </contact>
    <investigator>
      <last_name>Sashi Makam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ANI Neurology, PLLC dba Alzheimer's Memory Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28270</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marissa McRae</last_name>
      <phone>704-364-4000</phone>
      <phone_ext>235</phone_ext>
      <email>mmcrae@amcneurology.com</email>
    </contact>
    <investigator>
      <last_name>Mohammad Boulori, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Insight Clinical Trials, LLC</name>
      <address>
        <city>Beachwood</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisa Poggi</last_name>
      <phone>216-526-1843</phone>
      <email>epoggi1@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mark Stillman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurology Diagnostics Inc.</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45459</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ridwan Ahmad</last_name>
      <phone>937-224-8200</phone>
      <phone_ext>124</phone_ext>
      <email>ridwan.ahmad@neurologydiagnostics.com</email>
    </contact>
    <investigator>
      <last_name>Joel Vandersluis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memory Health Center at Summit Research Network</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tawnya</last_name>
      <phone>503-228-2273</phone>
      <email>oregon@summitnetwork.com</email>
    </contact>
    <investigator>
      <last_name>Scott Losk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northeastern Pennsylvania Memory and Alzheimer's Center</name>
      <address>
        <city>Plains</city>
        <state>Pennsylvania</state>
        <zip>18507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luanne Paul</last_name>
      <phone>570-262-0664</phone>
    </contact>
    <investigator>
      <last_name>Mario Cornacchione, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Senior Adults Specialty Research</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78757</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Velasquez</last_name>
      <phone>512-407-8628</phone>
      <email>mvelasquez@senioradults.net</email>
    </contact>
    <investigator>
      <last_name>Jaron Winston, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kerwin Research Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Vo</last_name>
      <phone>214-345-4449</phone>
      <email>Jennifervo@KerwinResearchCenter.com</email>
    </contact>
    <investigator>
      <last_name>Diana Kerwin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurology Consultants of Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75243</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Research Department</last_name>
      <phone>214-750-9977</phone>
      <phone_ext>293</phone_ext>
      <email>research@neurologydallas.com</email>
    </contact>
    <investigator>
      <last_name>Duc Tran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Department of Neurology</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Joseph Masdeu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Trial Network</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77074</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Contact</last_name>
      <phone>281-533-5000</phone>
    </contact>
    <investigator>
      <last_name>Djamchild Lotfi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia Adult Neurology</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Webber, CCRC</last_name>
      <phone>434-243-5898</phone>
      <email>cmn6x@virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Carol Manning, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Recognition Health</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Specialist Team</last_name>
      <phone>571-418-0142</phone>
      <email>marketing@re-cognitionhealth.com</email>
    </contact>
    <investigator>
      <last_name>Raymond Turner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwest Clinical Research Center</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>425-453-0404</phone>
      <email>study@nwcrc.net</email>
    </contact>
    <investigator>
      <last_name>Arifulla Khan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UW Alzheimer's Disease Research Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yeung Tutterow</last_name>
      <phone>206-897-6350</phone>
      <email>ylt2@uw.edu</email>
    </contact>
    <investigator>
      <last_name>Charles Bernick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin, Inc.</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barb Blaney</last_name>
      <phone>414-955-0609</phone>
    </contact>
    <investigator>
      <last_name>Malgorzata Franczak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de Brabois</name>
      <address>
        <city>Toulouse</city>
        <state>Cedex</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Carrie</last_name>
      <phone>+05 61 77 79 73</phone>
      <email>carrie.i@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Emmanuelle HULLIGER SAURT</last_name>
      <phone>+05 61 77 79 73</phone>
      <email>hulliger-saurt.e@chu-toulouse.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Pierre Jean Ousset, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de Ressources Biologiques</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Louis Vincent</last_name>
      <phone>+03 20 44 60 21</phone>
      <email>jean-louis.vincent@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Prof Florence Pasquier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital La Timone, Department of Neurology and Neuropsychology</name>
      <address>
        <city>Marseille Cedex 5</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Pelat</last_name>
      <phone>+33 491385928</phone>
      <email>julie.pelat@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Mathieu Ceccaldi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Gériatrie</name>
      <address>
        <city>Nice</city>
        <zip>6100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justine Lemaire</last_name>
      <phone>04 92 03 47 78</phone>
      <email>lemaire.j@chu-ice.fr</email>
    </contact>
    <investigator>
      <last_name>Renaud David, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Strasbourg, Centre d'Investigation Clinique, Hôpital Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thouma-La CHANTHAVINOUT</last_name>
      <phone>+33 (0) 3 88 12 84 23</phone>
      <email>thouma-la.chanthavinout@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Frederic Blanc, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de Nancy Hôpital de Brabois Service de Gériatrie</name>
      <address>
        <city>Vandoeuvre les Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georges Valérie</last_name>
      <phone>+03 83 15 52 58</phone>
      <email>v.georges@chru-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Anathase Benetos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brain Research Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081 GN</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evelien Norbart</last_name>
      <phone>+31 (0)203017170</phone>
      <email>e.norbart@brainresearchcenter.nl</email>
    </contact>
    <investigator>
      <last_name>Sterre Rutgers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PreCare Trial &amp; Recruitment</name>
      <address>
        <city>Beek</city>
        <zip>6191 JW</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vivienne van de Walle, MD</last_name>
      <phone>+31 (0)46 475 8687</phone>
      <email>info@ptr.nu</email>
    </contact>
    <investigator>
      <last_name>Vivienne van de Walle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brain Research Center Den Bosch B.V.</name>
      <address>
        <city>Den Bosch</city>
        <zip>5223 LA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Dautzenberg</last_name>
      <phone>+ 31 (0)73 200 4111</phone>
      <email>T.Dautzenberg@brainresearchcenter.nl</email>
    </contact>
    <investigator>
      <last_name>Paul Dautzenberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Isala Zwolle - Interne geneeskunde Centrum voor ouderengeneeskunde</name>
      <address>
        <city>Zwolle</city>
        <zip>8025 AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lonneke Buitenhuis</last_name>
      <phone>+31 38 424 8221</phone>
      <email>l.buitenhuis@isala.nl</email>
    </contact>
    <investigator>
      <last_name>Ad Kamper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brain Research Center Zwolle</name>
      <address>
        <city>Zwolle</city>
        <zip>8025 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ad Kamper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indywidualna Specjalistyczna Praktyka Lekarska</name>
      <address>
        <city>Gdańsk</city>
        <zip>80-438</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Włodarczyk</last_name>
      <phone>+48 503 642 588</phone>
      <email>aswlodarczyk@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Wiesław Jerzy Cubala, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NZOZ Wielospecjalistyczna Poradnia Lekarska SYNAPSIS</name>
      <address>
        <city>Katowice</city>
        <zip>40-123</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Blaszta</last_name>
      <phone>+48 602 643 900</phone>
      <email>annablaszta@vp.pl</email>
    </contact>
    <investigator>
      <last_name>Lech Szczechowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Plejady</name>
      <address>
        <city>Kraków</city>
        <zip>30-363</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Krakowska Akademia Neurologii</name>
      <address>
        <city>Kraków</city>
        <zip>31-505</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Pinkosz</last_name>
      <phone>+48 663 506 020</phone>
      <email>marta.pinkosz@neurologia.org.pl</email>
    </contact>
    <investigator>
      <last_name>Andrzej Szczudlik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NEURO-CARE Sp. z o.o. Sp. Komandytowa</name>
      <address>
        <city>Siemianowice Śląskie</city>
        <zip>41-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weronika Czarnik</last_name>
      <phone>+0048 539 333 444</phone>
      <email>w.czarnik@neuro-care.pl</email>
    </contact>
    <investigator>
      <last_name>Gabriela Klodowska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Euromedis Sp. z o.o.</name>
      <address>
        <city>Szczecin</city>
        <zip>70-111</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jakub Burdanowski</last_name>
      <phone>+48 91 813 63 22</phone>
      <email>jakub.burdanowski@euromedis.pl</email>
    </contact>
    <investigator>
      <last_name>Marcin Ratajczak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne NeuroProtect</name>
      <address>
        <city>Warszawa</city>
        <zip>01-684</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Biel</last_name>
      <phone>+48 22 468 15 48</phone>
      <email>marta.biel@neuroprotect.pl</email>
    </contact>
    <investigator>
      <last_name>Maciej Czarnecki, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NZOZ Wrocławskie Centrum Alzheimerowskie</name>
      <address>
        <city>Wrocław</city>
        <zip>53-659</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katarzyna Łuszczek</last_name>
      <phone>+48 691288132</phone>
      <email>katarina.sc@alzheimer.wroclaw.pl</email>
    </contact>
    <investigator>
      <last_name>Marzena Zboch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinica Gipuzkoa</name>
      <address>
        <city>San Sebastián</city>
        <state>Gipuzkoa</state>
        <zip>20014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gurutz Linazasoro, MD</last_name>
      <phone>+34943002818</phone>
      <phone_ext>3550</phone_ext>
    </contact>
    <investigator>
      <last_name>Gurutz Linazasoro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Alicante</name>
      <address>
        <city>Alicante</city>
        <zip>03010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosa Mª Sánchez Pérez, MD</last_name>
      <phone>+34 639 748 878</phone>
    </contact>
    <contact_backup>
      <last_name>Rosa Mª Sánchez Pérez, MD</last_name>
      <phone>+34 665 478 784</phone>
    </contact_backup>
    <investigator>
      <last_name>Rosa Mª Sánchez Pérez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>8005</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Blesa Gonzalez, MD</last_name>
      <phone>+34618846138</phone>
    </contact>
    <investigator>
      <last_name>Rafael Blesa Gonzalez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundacio Ace</name>
      <address>
        <city>Barcelona</city>
        <zip>8028</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Merce Boada, MD</last_name>
      <phone>+34 934304720</phone>
    </contact>
    <investigator>
      <last_name>Merce Boada, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>8036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mircea Balasa, MD</last_name>
      <phone>+34 93451 82 40</phone>
    </contact>
    <investigator>
      <last_name>Mircea Balasa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón Y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillermo Garcia Ribas, MD</last_name>
      <phone>+34629385547</phone>
    </contact>
    <investigator>
      <last_name>Guillermo Garcia Ribas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari General de Catalunya</name>
      <address>
        <city>Sant Cugat Del Vallès</city>
        <zip>8195</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ernest Balaguer Martinez, MD</last_name>
      <phone>+34 937 151 575</phone>
    </contact>
    <investigator>
      <last_name>Ernest Balaguer Martinez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascual Sanchez Juan, MD</last_name>
      <phone>+34942204084</phone>
    </contact>
    <investigator>
      <last_name>Pascual Sanchez Juan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cognition Health Birmingham (private)</name>
      <address>
        <city>Edgbaston</city>
        <state>Birmingham</state>
        <zip>B16 8LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Faulkner, MD</last_name>
      <phone>441216550174</phone>
      <email>gziff@re-cognitionhealth.com</email>
    </contact>
    <investigator>
      <last_name>Karen Faulkner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Pancras Clinical Research (private)</name>
      <address>
        <city>Barbican</city>
        <state>London</state>
        <zip>EC2Y 8EA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Perez</last_name>
      <phone>+0203 8651142</phone>
      <email>cristinaperez@stpancrasclinical.com</email>
    </contact>
    <investigator>
      <last_name>John Ndikum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cognition Health Plymouth</name>
      <address>
        <city>Plymouth</city>
        <state>Science Park</state>
        <zip>PL5 8BT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannah Smith</last_name>
      <phone>+(01752) 875604</phone>
      <email>hsmith@re-cognitionhealth.com</email>
    </contact>
    <investigator>
      <last_name>Stephen Pearson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memory Assessment and Research Centre, Moorgreen Hospital</name>
      <address>
        <city>Southampton</city>
        <state>UK</state>
        <zip>SO30 3JB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Clive Holmes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>RICE - The Research Institute for the Care of Older People</name>
      <address>
        <city>Bath</city>
        <zip>BA1 3NG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne Roots</last_name>
      <phone>44 (0)1225 476420</phone>
      <email>mr699@bath.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Roy Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Glasgow Memory Clinic</name>
      <address>
        <city>Glasgow</city>
        <zip>G20 0XA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorna Wallace</last_name>
      <phone>1419480206</phone>
      <email>info@glasgowmemoryclinic.com</email>
    </contact>
    <investigator>
      <last_name>Jennifer Lynch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cognition Health Ltd. (private) Guildford</name>
      <address>
        <city>Guildford</city>
        <zip>GU2 7YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmad Ebadi</last_name>
      <phone>+441483388020</phone>
      <email>aebadi@re-cognitionhealth.com</email>
    </contact>
    <investigator>
      <last_name>Emer MacSweeney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cognition Health Ltd. (private) London</name>
      <address>
        <city>London</city>
        <zip>W1G 9JF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emer MacSweeney, MD</last_name>
      <phone>+442033553536</phone>
    </contact>
    <investigator>
      <last_name>Emer MacSweeney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kingshill Research Centre Swindon</name>
      <address>
        <city>Swindon</city>
        <zip>SN3 6BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Hall</last_name>
      <phone>01793327954</phone>
      <email>carol.hall11@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Sabarigirivasan Muthukrishnan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 24, 2019</study_first_submitted>
  <study_first_submitted_qc>January 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2019</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

